{"id":6,"date":"2022-03-31T02:33:18","date_gmt":"2022-03-31T02:33:18","guid":{"rendered":"http:\/\/box5586.temp.domains\/~ehyperte\/?page_id=6"},"modified":"2022-06-07T05:29:31","modified_gmt":"2022-06-07T05:29:31","slug":"about","status":"publish","type":"page","link":"https:\/\/ehypertension.org\/?page_id=6","title":{"rendered":"About"},"content":{"rendered":"\n <\/div>
\n <\/a>\n \n <\/div>
\n \n
<\/div>\n \n<\/div>\n
\n \n <\/div>

Brief introduction about the eHypertension<\/font><\/span><\/h2>

The eHypertension aims to recruit 500 healthy controls and 2000 essential hypertension patients in southeast China. More than 400 phenotypes will be recorded, including psychosocial characteristics, physical measurements, biochemical parameters, environmental factors and clinical status. Besides, fasting blood, urine and stool samples will be collected for omics profiling, such as genome, metagenome, metabolome and others. For essential hypertension patients, randomized antihypertensive interventions will be carried out and the patients will be followed up for 10 years. <\/font><\/span><\/p> <\/div> <\/div><\/div>

<\/div> <\/div><\/div><\/div><\/div><\/div>\n <\/div>\n<\/section>\n